1. Home
  2. SDHC vs IPSC Comparison

SDHC vs IPSC Comparison

Compare SDHC & IPSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Smith Douglas Homes Corp.

SDHC

Smith Douglas Homes Corp.

HOLD

Current Price

$11.23

Market Cap

162.0M

Sector

N/A

ML Signal

HOLD

Logo Century Therapeutics Inc.

IPSC

Century Therapeutics Inc.

HOLD

Current Price

$2.47

Market Cap

189.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SDHC
IPSC
Founded
2008
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
162.0M
189.7M
IPO Year
2023
2021

Fundamental Metrics

Financial Performance
Metric
SDHC
IPSC
Price
$11.23
$2.47
Analyst Decision
Hold
Strong Buy
Analyst Count
5
5
Target Price
$14.60
$3.50
AVG Volume (30 Days)
169.3K
1.1M
Earning Date
03-11-2026
03-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
91.30
EPS
1.19
N/A
Revenue
$971,116,000.00
$109,164,000.00
Revenue This Year
$7.71
N/A
Revenue Next Year
$11.19
N/A
P/E Ratio
$9.74
N/A
Revenue Growth
N/A
1556.76
52 Week Low
$11.24
$0.34
52 Week High
$23.50
$2.97

Technical Indicators

Market Signals
Indicator
SDHC
IPSC
Relative Strength Index (RSI) 27.77 55.55
Support Level $11.24 $0.49
Resistance Level $22.05 $2.71
Average True Range (ATR) 1.05 0.25
MACD -0.10 -0.04
Stochastic Oscillator 3.17 42.77

Price Performance

Historical Comparison
SDHC
IPSC

About SDHC Smith Douglas Homes Corp.

Smith Douglas Homes Corp is a company engaged in the design, construction, and sale of single-family homes in some of the highest growth and desirable markets in the Southeastern United States. It is organized into eight geographical divisions which comprise two reportable segments. Its Southeast segment consists of Atlanta, Central Georgia, Charlotte, Greenville, and Raleigh divisions. Its Central segment consists of Alabama, Houston, and Nashville divisions.

About IPSC Century Therapeutics Inc.

Century Therapeutics Inc is a biotechnology company that specializes in leveraging adult stem cells to develop cell therapy products aimed at treating cancer, autoimmune disorders, and inflammatory diseases. Their features a genetically engineered allogeneic cell therapy platform that incorporates induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and manufacturing capabilities. This comprehensive platform seeks to address the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and reducing development and supply risks.

Share on Social Networks: